Compounders Research Compare

CeriBell, Inc.(CBLL)

Medical - Devices · Sunnyvale, CA

$24.95+0.09 (+0.36%)

Delayed quote: Oct 6, 2026, 9:30 AM EDT

About CeriBell, Inc.

CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.

Sunnyvale, CA

327 employees

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Xingjuan Chao

View full financials

Price/FCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T13:30:55.127Z.

Stored calculation inputs

Calculation as of: 2026-10-06T13:30:55.127Z.

Quote observation: 2026-10-06T13:30:02.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 946,670,365
TTM free cash flow · period ending 2026-06-30: -56,331,000

FMP input reference: cf0630fc9642b75147419b140bafddb7ccff0a2362c2d95f2dd7172ee2000ae5

P/E Ratio|FCF Growth|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

CBLL Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

CBLL Competitors' Price/FCF Ratio

CeriBell, Inc.

Current

Market Cap

$946.67M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Kura Oncology, Inc.

Market Cap

$954.32M

Price/FCF Ratio

N/A

TTM Avg

6.84

3Y Avg

6.83

5Y Avg

6.83

Arbutus Biopharma Corp

Market Cap

$892.87M

Price/FCF Ratio

N/A

TTM Avg

27.25

3Y Avg

19.97

5Y Avg

19.97

HealthStream, Inc.

Market Cap

$921.89M

Price/FCF Ratio

18.87

TTM Avg

13.52

3Y Avg

15.51

5Y Avg

16.87

Bioventus Inc.

Market Cap

$916.63M

Price/FCF Ratio

9.72

TTM Avg

9.57

3Y Avg

34.87

5Y Avg

48.37

Corvus Pharmaceuticals, Inc.

Market Cap

$903.97M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Aktis Oncology, Inc.

Market Cap

$988.93M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LB Pharmaceuticals Inc Common Stock

Market Cap

$1.01B

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Monte Rosa Therapeutics, Inc.

Market Cap

$876.90M

Price/FCF Ratio

N/A

TTM Avg

12.01

3Y Avg

12.01

5Y Avg

12.01

Janux Therapeutics, Inc.

Market Cap

$1.02B

Price/FCF Ratio

N/A

TTM Avg

558.39

3Y Avg

558.39

5Y Avg

558.39

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
CeriBell, Inc. (CBLL)	$946.67M	N/A	N/A	N/A	N/A
Kura Oncology, Inc. (KURA)vs ›	$954.32M	N/A	6.84	6.83	6.83
Arbutus Biopharma Corp (ABUS)vs ›	$892.87M	N/A	27.25	19.97	19.97
HealthStream, Inc. (HSTM)vs ›	$921.89M	18.87	13.52	15.51	16.87
Bioventus Inc. (BVS)vs ›	$916.63M	9.72	9.57	34.87	48.37
Corvus Pharmaceuticals, Inc. (CRVS)vs ›	$903.97M	N/A	N/A	N/A	N/A
Aktis Oncology, Inc. (AKTS)vs ›	$988.93M	N/A	N/A	N/A	N/A
LB Pharmaceuticals Inc Common Stock (LBRX)vs ›	$1.01B	N/A	N/A	N/A	N/A
Monte Rosa Therapeutics, Inc. (GLUE)vs ›	$876.90M	N/A	12.01	12.01	12.01
Janux Therapeutics, Inc. (JANX)vs ›	$1.02B	N/A	558.39	558.39	558.39

Free Cash Flow Valuation

P/FCF Ratio

N/A

FCF Yield

N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Growth Operating Margin All Metrics